Skip to main content
SpringerLink
Log in

Lung Cancer Screening Results and Tracking

  • Chapter
  • First Online:
Book cover Lung Cancer Screening

  • 239 Accesses

Abstract

This chapter provides practical information about the ordering, interpretation, reporting and tracking results of lung cancer screening. Guidelines for managing incidental findings are discussed. Updates on new technologies in lung cancer screening (LCS) are provided. The special considerations of women and LCS are also addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. US Preventive Services Task Force. Screening for lung cancer US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325:962–70.

    Article  Google Scholar 

  2. Centers for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). 2015. https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.

  3. Tammimagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728–36.

    Article  Google Scholar 

  4. Tammimagi MC, ten Haaf K, Toumazis I, et al. Development and validation of a multivariable Lung Cancer Risk Prediction Model that includes low-dose computed tomography screening results. JAMA Netw Open. 2019;2(3):e190204. https://doi.org/10.1001/jamanetworkopen.2019.0204.

    Article  Google Scholar 

  5. Pasquinelli MM, Tammemagi MC, Kovitz KL, et al. Risk prediction model versus United States Preventive Services Task Force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol. 2020;15(11):1738–47.

    Article  Google Scholar 

  6. American College of Radiology. Lung CT Screening Reporting & Data System (LungRADS Version 1.1). https://www.acr.org/LungRADS.

  7. IELCAP. International v Early Lung Cancer Action Program: Screening Protocol. https://www.ielcap.org/Management.

  8. Deppen SA, Grogan EL, Aldrich MC, Massion PP. Lung cancer screening and smoking cessation: a teachable moment. JNCI. 2014;106:1–2.

    Article  Google Scholar 

  9. American College of Radiology. Lung Cancer Screening Registry. https://www.acr.org/LCSR.

  10. IASLC Language Guide. 2021. IASLC. https://www.iaslc.orf/IASLCLanguageGuide.

  11. McWillaims A, Tammemagi MC, Mayo JR, et al. Probability of lung cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910–9.

    Article  Google Scholar 

  12. White CS, Dharaiya E, Dalal S, et al. Vancouver risk calculator compared with ACR LungRADS in predicting malignancy: analysis of the National Lung Cancer Screening Trial. Radiology. 2019;291:205–11.

    Article  Google Scholar 

  13. Choi HK, Ghobrial M, Mazzone PJ, et al. Models to estimate the probability of malignancy in patients with pulmonary nodules. Ann Am Thorac Soc. 2018;15(10):1117–26.

    Article  Google Scholar 

  14. Penna R, Lim J, Williams BL, et al. Opportunistic screening of patients for hepatic steatosis: clinical follow-up and diagnostic yield. J Am Coll Radiol. 2021;18:1423–9.

    Article  Google Scholar 

  15. Boutin RD, Lenchik L. Value-added opportunistic CT: insights into osteoporosis and sarcopenia. AJR. 2020;215:582–94.

    Article  Google Scholar 

  16. Kinsinger LS, Anderson C, Kim J, et al. Implementation of lung cancer screening in the Veterans Health Administration. JAMA Intern Med. 2017;177(3):399–406.

    Article  Google Scholar 

  17. Janssen K, Schertz K, Rubin N, Begnaud A. Incidental findings in a Decentralized Lung Cancer Screening Program. Ann Am Thorac Soc. 2019;16(9):1198–200.

    Article  Google Scholar 

  18. Reiter MJ, Nemesure A, Madu E, et al. Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in lung cancer screening program. Lung Cancer. 2018;120:1–6.

    Article  Google Scholar 

  19. Nguyen XV, Davies L, Eastwood JD, Hoang JK. Extrapulmonary findings and malignancies in participants screened with chest CT in the National Lung Screening Trial. J Am Coll Radiol. 2017;14:324–30.

    Article  Google Scholar 

  20. Tsai EB, Chiles C, Carter BW, et al. Incidental findings on lung cancer screening: significance and management. Semin Ultrasound CT MR. 2018;39:273–81.

    Article  Google Scholar 

  21. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  Google Scholar 

  22. Chung JH, Richards JC, Koelsch TL, et al. Screening for lung cancer: incidental pulmonary parenchymal findings. AJR. 2018;210:1–11.

    Article  Google Scholar 

  23. Morgan L, Choi H, Reid M, Khawaja A, Mazzone PJ. Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening. Ann Am Thorac Soc. 2017;14:1450–6.

    Article  Google Scholar 

  24. Steiger D, Siddiqi MF, Yip R, et al. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD. Clin Imaging. 2021;78:136–41.

    Article  Google Scholar 

  25. Chiles C, Duan F, Gladish GW, et al. Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods. Radiology. 2015;276(1):82–90.

    Article  Google Scholar 

  26. Kucharczyk MJ, Menezes RJ, McGregor A, et al. Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J. 2011;62:141–5.

    Article  Google Scholar 

  27. Rampinelli C, Preda L, Maniglio M, et al. Extrapulmonary malignancies detected at lung cancer screening. Radiology. 2011;261:293–9.

    Article  Google Scholar 

  28. Kauczor HU, Baird AM, Blum TG, et al. ESR/ERS statement paper on lung cancer screening. Eur Respir J. 2020;55(2):1900506. https://doi.org/10.1183/13993003.00506-2019.

    Article  PubMed  Google Scholar 

  29. Munden RF, Carter BW, Chiles C, et al. Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018;15:1087–96.

    Article  Google Scholar 

  30. Munden RF, Black WC, Hartman TE, et al. Managing incidental findings on thoracic CT: lung findings. A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2021;18(9):1267–79.

    Article  Google Scholar 

  31. Gore RM, Pickhardt PJ, Mortele KJ, et al. Management of incidental liver lesions on CT: a White paper of the ACR Incidental Findings Committee. Am Coll Radiol. 2017;13:1429–37.

    Article  Google Scholar 

  32. Mayo-Smith WW, Song JH, Boland GL, et al. Management of incidental adrenal masses: a White Paper of the ACR Incidental Findings Committee. Am Coll Radiol. 2017;14:1038–44.

    Article  Google Scholar 

  33. Herts BR, Silverman SG, Hindman NM, et al. Management of the incidental renal mass on CT: a White Paper of the ACR Incidental Findings Committee. Am Coll Radiol. 2018;15:264–73.

    Article  Google Scholar 

  34. Megibow AJ, Baker ME, Morgan DE, et al. Management of the incidental pancreatic cysts: a White Paper of the ACR Incidental Findings Committee. Am Coll Radiol. 2017;14:911–23.

    Article  Google Scholar 

  35. Gareen IF, Black WC, Tosteson TD, et al. Medical care cost were similar across the low-dose computed tomography and chest x-ray arms of the National Lung Screening Trial despite different rates of significant incidental findings. Med Care. 2018;56(5):403–9.

    Article  Google Scholar 

  36. Gierada DS, Black WC, Chiles C, et al. Low-dose screening for lung cancer: evidence from 2 decades of study. Radiol Imaging Cancer. 2020;2(2):e190058. https://doi.org/10.1148/rycan.2020190058.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Godoy MCB, White CS, Erasmus JJ, et al. Extrapulmonary neoplasms in lung cancer screening. Transl Lung Cancer Res. 2018;7(3):368–75.

    Article  Google Scholar 

  38. Horeweg N, van der Aalst CM, Vliegenthart R. Volumetric computed tomography for lung cancer: three rounds of the NELSON trial. Eur Respir J. 2013;42:1659–67.

    Article  Google Scholar 

  39. De Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503–13.

    Article  Google Scholar 

  40. Schreuder A, Scholten ET, van Ginneken B, Jacobs C. Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice? Transl Lung Cancer Res. 2021;10(5):2378–88.

    Article  Google Scholar 

  41. Mathew CJ, David AM, Mathew CMJ. Artificial intelligence and its future potential in lung cancer screening. EXCLI J. 2020;19:1552–62.

    Google Scholar 

  42. Chamberlin J, Kocher MR, Waltz J. Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value. BMC Med. 2021;19(1):55. https://doi.org/10.1186/s12916-021-01928-3.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Binczyk F, Prazuch W, Bozek P, Polanska J. Radiomics and artificial intelligence in lung cancer screening. Transl Lung Cancer Rev. 2021;10(2):1186–99.

    Article  Google Scholar 

  44. Espinoza JL, Dong LT. Artificial intelligence tools for refining lung cancer screening. J Clin Med. 2020;9:1–17.

    Article  Google Scholar 

  45. Lam S, Tammemagi M. Contemporary issues in the implementation of lung cancer screening. Eur Respir Rev. 2021;30:1–17.

    Article  Google Scholar 

  46. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442. (In Eng)

    Article  PubMed  Google Scholar 

  47. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975-2015. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2015/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018.

  48. National Lung Health Barometer. LUNG FORCE. https://www.lung.org/lung-force/lung-health-barometer2020.

  49. Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening-results from the randomized German LUSI trial. Int J Cancer. 2020;146(6):1503–13. https://doi.org/10.1002/ijc.32486. (In Eng)

    Article  CAS  PubMed  Google Scholar 

  50. Schiebinger L. Women’s health and clinical trials. J Clin Invest. 2003;112(7):973–7. https://doi.org/10.1172/JCI19993. (In Eng)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. National Lung Screening Trial Research T, Aberle DR, Adams AM, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010;102(23):1771–9. https://doi.org/10.1093/jnci/djq434. (In Eng)

    Article  Google Scholar 

  52. Yong PC, Sigel K, Rehmani S, Wisnivesky J, Kale MS. Lung cancer screening uptake in the United States. Chest. 2020;157(1):236–8. https://doi.org/10.1016/j.chest.2019.08.2176.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Okereke IC, Nishi S, Zhou J, Goodwin JS. Trends in lung cancer screening in the United States, 2016-2017. J Thorac Dis. 2019;11(3):873–81. https://doi.org/10.21037/jtd.2019.01.105. (In Eng)

    Article  PubMed  PubMed Central  Google Scholar 

  54. Warner ET, Lathan CS. Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013–2017. Prev Med. 2019;124:84–90. https://doi.org/10.1016/j.ypmed.2019.05.001.

    Article  PubMed  Google Scholar 

  55. Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol. 2019;5(9):1318–24. https://doi.org/10.1001/jamaoncol.2019.1402.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Ritzwoller DP, Meza R, Carroll NM, et al. Evaluation of population-level changes associated with the 2021 US force lung cancer screening recommendations in community-based health care systems. JAMA Netw Open. 2021;4(10):e2128176. https://doi.org/10.1001/jamanetworkopen.2021.28176.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Wu GX, Goldstein L, Kim JY, Raz DJ. Proportion of non-small-cell lung cancer patients that would have been eligible for lung cancer screening. Clin Lung Cancer. 2016;17(5):e131–9. https://doi.org/10.1016/j.cllc.2016.01.001. (In Eng)

    Article  PubMed  PubMed Central  Google Scholar 

  58. Meza R, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: a collaborative modeling study for the U.S. Preventive Services Task Force. (CISNET) and L. C. Work Group. Rockville, MD 20857. Agency for Healthcare Research and Quality. AHRQ Publication No. 20-05266-EF-2 July 2020: 177; 2020.

    Google Scholar 

  59. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291(14):1763–8. https://doi.org/10.1001/jama.291.14.1763.

    Article  CAS  PubMed  Google Scholar 

  60. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer. 1993;54(1):44–8. https://doi.org/10.1002/ijc.2910540108.

    Article  CAS  PubMed  Google Scholar 

  61. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007;55(1):15–23. https://doi.org/10.1016/j.lungcan.2006.09.008.

    Article  PubMed  Google Scholar 

  62. Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25(5):472–8. https://doi.org/10.1200/JCO.2006.07.2983. (In Eng)

    Article  PubMed  Google Scholar 

  63. Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 2000;92(1):24–33. https://doi.org/10.1093/jnci/92.1.24. (In Eng)

    Article  CAS  PubMed  Google Scholar 

  64. Jemal A, Miller KD, Ma J, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378(21):1999–2009. https://doi.org/10.1056/NEJMoa1715907.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Maki KG, Shete S, Volk RJ. Examining lung cancer screening utilization with public-use data: opportunities and challenges. Prev Med. 2021;147:106503. https://doi.org/10.1016/j.ypmed.2021.106503. (In Eng)

    Article  PubMed  Google Scholar 

  66. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528–40. https://doi.org/10.1002/cncr.11208. (In Eng)

    Article  PubMed  Google Scholar 

  67. López DB, Flores EJ, Miles RC, et al. Assessing eligibility for lung cancer screening among women undergoing screening mammography: cross-sectional survey results from the National Health Interview Survey. J Am Coll Radiol. 2019;16(10):1433–9. https://doi.org/10.1016/j.jacr.2019.04.006.

    Article  PubMed  Google Scholar 

  68. Sandler KL, Haddad DN, Paulson AB, et al. Women screened for breast cancer are dying from lung cancer: an opportunity to improve lung cancer screening in a mammography population. J Med Screen. 2021;28(4):488–93. https://doi.org/10.1177/09691413211013058.

    Article  PubMed  Google Scholar 

  69. Lin KF, Wu HF, Huang WC, Tang PL, Wu MT, Wu FZ. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer. BMC Pulm Med. 2017;17(1):120. https://doi.org/10.1186/s12890-017-0465-8. (In Eng)

    Article  PubMed  PubMed Central  Google Scholar 

  70. Kim HY, Jung KW, Lim KY, et al. Lung cancer Screening with low-dose CT in female never smokers: retrospective cohort study with long-term national data follow-up. Cancer Res Treat. 2018;50(3):748–56. https://doi.org/10.4143/crt.2017.312. (In Eng)

    Article  PubMed  Google Scholar 

  71. Chien LH, Chen CH, Chen TY, et al. Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model. Cancer Epidemiol Biomark Prev. 2020;29(2):452–9. https://doi.org/10.1158/1055-9965.Epi-19-1221. (In Eng)

    Article  Google Scholar 

  72. Kang HR, Cho JY, Lee SH, et al. Role of low-dose computerized tomography in lung cancer screening among never-smokers. J Thorac Oncol. 2019;14(3):436–44. https://doi.org/10.1016/j.jtho.2018.11.002. (In Eng)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, National Jewish Health, Denver, CO, USA

    Debra S. Dyer

  2. Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA

    Kim L. Sandler

Authors
  1. Debra S. Dyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim L. Sandler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Debra S. Dyer .

Editor information

Editors and Affiliations

  1. Division of PulmonaryCritical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Janelle V. Baptiste

  2. Division of PulmonaryCritical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Richard M. Schwartzstein

  3. Division of Pulmonary and Critical Care Medicine, Mt Auburn Hospital/Beth Israel Lahey Health, Harvard Medical School, Boston, MA, USA

    Carey C. Thomson

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dyer, D.S., Sandler, K.L. (2022). Lung Cancer Screening Results and Tracking. In: Baptiste, J.V., Schwartzstein, R.M., Thomson, C.C. (eds) Lung Cancer Screening. Springer, Cham. https://doi.org/10.1007/978-3-031-10662-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-10662-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-10661-3

  • Online ISBN: 978-3-031-10662-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation